- Home
- AVIR vs EB Comparison
AVIR vs EB Comparison
Compare AVIR & EB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- EB
- Stock Information
- Founded
- AVIR 2012
- EB 2003
- Country
- AVIR United States
- EB United States
- Employees
- AVIR N/A
- EB N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- EB EDP Services
- Sector
- AVIR Health Care
- EB Technology
- Exchange
- AVIR Nasdaq
- EB Nasdaq
- Market Cap
- AVIR 290.4M
- EB 255.7M
- IPO Year
- AVIR 2020
- EB 2018
- Fundamental
- Price
- AVIR $3.37
- EB $2.63
- Analyst Decision
- AVIR Hold
- EB Buy
- Analyst Count
- AVIR 1
- EB 2
- Target Price
- AVIR $6.00
- EB $5.25
- AVG Volume (30 Days)
- AVIR 306.9K
- EB 712.2K
- Earning Date
- AVIR 11-06-2025
- EB 11-06-2025
- Dividend Yield
- AVIR N/A
- EB N/A
- EPS Growth
- AVIR N/A
- EB N/A
- EPS
- AVIR N/A
- EB N/A
- Revenue
- AVIR N/A
- EB $300,856,000.00
- Revenue This Year
- AVIR N/A
- EB N/A
- Revenue Next Year
- AVIR N/A
- EB $9.53
- P/E Ratio
- AVIR N/A
- EB N/A
- Revenue Growth
- AVIR N/A
- EB N/A
- 52 Week Low
- AVIR $2.46
- EB $1.81
- 52 Week High
- AVIR $4.15
- EB $4.12
- Technical
- Relative Strength Index (RSI)
- AVIR 42.27
- EB 52.45
- Support Level
- AVIR $3.35
- EB $2.58
- Resistance Level
- AVIR $3.86
- EB $2.76
- Average True Range (ATR)
- AVIR 0.13
- EB 0.11
- MACD
- AVIR -0.02
- EB 0.00
- Stochastic Oscillator
- AVIR 14.78
- EB 35.14
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.